Interrogating Maladaptive Serotonin Raphe-Striatal Plasticity in L-DOPA-Induced Dyskinesia
探讨左旋多巴引起的运动障碍中血清素适应不良的中缝纹状体可塑性
基本信息
- 批准号:10531913
- 负责人:
- 金额:$ 65.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-01 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AnatomyAnimal Disease ModelsAutomobile DrivingAutopsyAutoreceptorsBasic ScienceBehaviorBehavioralBrainBrain DiseasesCellsClinicalClinical SciencesCorpus striatum structureDataDenervationDevelopmentDopamineDyskinetic syndromeElectrophysiology (science)Experimental ParkinsonismFiberGeneticGoalsHomeostasisHumanHyperactivityInterventionInvestigationKnowledgeL-DOPA induced dyskinesiaLevodopaLinkMediatingMethodsMicrodialysisMicroscopyMidbrain structureMinorityNeuronal PlasticityNeuronsNeurosciencesNeurotransmittersOutputParkinson DiseaseParkinsonian DisordersPathway interactionsPatientsPharmaceutical PreparationsPhenotypePhotometryPre-Clinical ModelQuality of lifeRattusResearchResearch PersonnelSerotoninSourceSynapsesTPH2TechniquesTechnologyTestingTimeTissuesabnormal involuntary movementcostdesigner receptors exclusively activated by designer drugsdopamine replacement therapygain of functiongenetic approachimprovedin vivoinnovationinsightinterestneurochemistryneurotransmissionneurotransmitter releasenovelnovel strategiesoptimal treatmentspre-clinicalpreventprospectiveside effectstandard carestemtooltreatment strategy
项目摘要
PROJECT SUMMARY/ABSTRACT:
L-DOPA remains the gold-standard treatment for Parkinson’s disease (PD). Unfortunately, within a decade of
commencing L-DOPA, nearly 90% of PD patients develop intractable abnormal involuntary movements known as L-
DOPA-induced dyskinesias (LID), severely impacting quality of life. Research implicates serotonin (5-HT) neurons
as a source of LID as they can take up L-DOPA, convert it to dopamine (DA), and release DA as an unregulated
“false neurotransmitter” leading to a dyskinesogenic phenotype. Although treatments aimed at alleviating LID have
emerged, only a minority of patients benefit due to their cost, side effects and/or invasiveness. Moreover, we
have yet to find a way to prevent LID development, in part due to major gaps in knowledge on how L-DOPA
treatment instigates maladaptive 5-HT reorganization and aberrant striatal output. Our research team has
recently collected preliminary data using novel approaches that provide exciting new insights into the
mechanisms of 5-HT neuroplasticity that will enlighten both basic and clinical science. These convergent findings
led us to postulate our Central Hypothesis that maladaptive 5-HT-raphe-striatal neurocircuit plasticity
precipitates and maintains LID. The overarching goal for our multi-investigator team is to identify the mechanisms
underlying the development of structural and functional maladaptation within the raphe-striatal circuit driving LID,
which in turn could lead to novel, optimized targets for intervention. We will fill this knowledge gap through the
pursuit of 3 independent, but inter-related Specific Aims. Our 3 Specific Aims will: 1) define the extent to which
DA denervation and/or L-DOPA treatment results in anatomical and functional reorganization of the 5-HT raphe-
striatal pathway in PD and experimental parkinsonism, 2) use projection-specific chemogenetic modulations to
determine the impact of the 5-HT raphe-striatal activity on L-DOPA-induced anti-parkinsonian efficacy and
dyskinesia, and 3) establish how regulating DA release from 5-HT raphe-striatal neurons prevents the
development of LID and associated maladaptive neuronal changes. The proposed cross-species investigation will
establish neuroplasticity within the 5-HT raphe-striatal circuit as a foremost factor in the development and expression
of LID and in so doing, identify optimal treatment strategies to improve the quality of life for millions of current and
prospective PD patients.
项目概要/摘要:
左旋多巴仍然是治疗帕金森病 (PD) 的金标准。不幸的是,十年之内
开始使用 L-DOPA 后,近 90% 的 PD 患者会出现顽固性异常不自主运动,称为 L-
多巴引起的运动障碍(LID),严重影响生活质量。研究涉及血清素 (5-HT) 神经元
作为 LID 的来源,因为它们可以吸收 L-DOPA,将其转化为多巴胺 (DA),并以不受管制的形式释放 DA
“假神经递质”导致运动障碍表型。尽管旨在减轻 LID 的治疗已
出现后,由于其成本、副作用和/或侵入性,只有少数患者受益。此外,我们
尚未找到预防 LID 发展的方法,部分原因是对于左旋多巴如何发挥作用的知识存在重大差距
治疗会引发适应不良的 5-HT 重组和异常的纹状体输出。我们的研究团队有
最近使用新颖的方法收集了初步数据,这些数据提供了令人兴奋的新见解
5-HT 神经可塑性的机制将启发基础科学和临床科学。这些趋同的发现
引导我们提出我们的中心假设:适应不良的 5-HT-中缝纹状体神经回路可塑性
沉淀并维持 LID。我们的多研究者团队的首要目标是确定机制
驱动 LID 的中缝-纹状体回路内结构和功能适应不良的发展的基础,
这反过来又可能导致新的、优化的干预目标。我们将通过以下方式填补这一知识空白:
追求 3 个独立但相互关联的具体目标。我们的 3 个具体目标将: 1) 定义
DA 去神经术和/或 L-DOPA 治疗导致 5-HT 中缝的解剖和功能重组
PD 和实验性帕金森病中的纹状体通路,2) 使用投射特异性化学遗传学调节
确定 5-HT 中缝纹状体活性对 L-DOPA 诱导的抗帕金森病功效的影响和
运动障碍,3) 确定调节 5-HT 中缝纹状体神经元释放 DA 如何预防运动障碍
LID 的发展和相关的适应不良神经元变化。拟议的跨物种调查将
建立 5-HT 中缝纹状体回路内的神经可塑性作为发育和表达的最重要因素
LID 的研究,并在此过程中确定最佳治疗策略,以改善数以百万计的当前和
潜在的 PD 患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER R BISHOP其他文献
CHRISTOPHER R BISHOP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER R BISHOP', 18)}}的其他基金
Interrogating maladaptive serotonin raphe-striatal plasticity in L-DOPA-induced dyskinesia
探讨 L-DOPA 引起的运动障碍中血清素适应不良的中缝纹状体可塑性
- 批准号:
10366348 - 财政年份:2021
- 资助金额:
$ 65.12万 - 项目类别:
Regulation of L-DOPA-induced dyskinesia by 5-HT1A receptor mechanisms
5-HT1A 受体机制调节 L-DOPA 诱导的运动障碍
- 批准号:
8073419 - 财政年份:2008
- 资助金额:
$ 65.12万 - 项目类别:
Regulation of L-DOPA-induced dyskinesia by 5-HT1A receptor mechanisms
5-HT1A 受体机制调节 L-DOPA 诱导的运动障碍
- 批准号:
7458306 - 财政年份:2008
- 资助金额:
$ 65.12万 - 项目类别:
Regulation of L-DOPA-induced dyskinesia by 5-HT1A receptor mechanisms
5-HT1A 受体机制调节 L-DOPA 诱导的运动障碍
- 批准号:
7614163 - 财政年份:2008
- 资助金额:
$ 65.12万 - 项目类别:
Regulation of L-DOPA-induced dyskinesia by 5-HT1A receptor mechanisms
5-HT1A 受体机制调节 L-DOPA 诱导的运动障碍
- 批准号:
8247115 - 财政年份:2008
- 资助金额:
$ 65.12万 - 项目类别:
Regulation of L-DOPA-induced dyskinesia by 5-HT1A receptor mechanisms
5-HT1A 受体机制调节 L-DOPA 诱导的运动障碍
- 批准号:
7800932 - 财政年份:2008
- 资助金额:
$ 65.12万 - 项目类别:
EFFECTS OF NICOTINE ON NPY FEEDING AND METABOLISM
尼古丁对 NPY 摄食和代谢的影响
- 批准号:
6174615 - 财政年份:2000
- 资助金额:
$ 65.12万 - 项目类别:
EFFECTS OF NICOTINE ON NPY FEEDING AND METABOLISM
尼古丁对 NPY 摄食和代谢的影响
- 批准号:
6013280 - 财政年份:1999
- 资助金额:
$ 65.12万 - 项目类别:
相似海外基金
Investigating how TRAF1 Controls Inflammasome Activation in Animal Disease Models of Inflammatory Arthritis and Peritonitis
研究 TRAF1 如何控制炎症性关节炎和腹膜炎动物疾病模型中的炎症小体激活
- 批准号:
449429 - 财政年份:2020
- 资助金额:
$ 65.12万 - 项目类别:
Studentship Programs
Establishment of animal disease models for intractable pediatric diseases due to defects of RNA metabolism and development of new therapeutics
RNA代谢缺陷引起的儿科疑难疾病动物模型的建立及新疗法的开发
- 批准号:
20H03644 - 财政年份:2020
- 资助金额:
$ 65.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of type 2 diabetes susceptibility genes using animal disease models
利用动物疾病模型对2型糖尿病易感基因进行功能分析
- 批准号:
18K08466 - 财政年份:2018
- 资助金额:
$ 65.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cell therapy of adipocytes derived from human iPS cells using cellcontainers and animal disease models
使用细胞容器和动物疾病模型对源自人类 iPS 细胞的脂肪细胞进行细胞治疗
- 批准号:
24659444 - 财政年份:2012
- 资助金额:
$ 65.12万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of genes involved in the pathogenesis of the arthritis using animal disease models..
使用动物疾病模型分析涉及关节炎发病机制的基因。
- 批准号:
17500284 - 财政年份:2005
- 资助金额:
$ 65.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ESTABLISHMENT OF THE DEVELOPING AND SUPPLING SYSTEMS FOR NEW ANIMAL,DISEASE MODELS FROM SUBSPECIES OF THE MOUSE
小鼠亚种新动物、疾病模型的开发和供应体系的建立
- 批准号:
07556128 - 财政年份:1995
- 资助金额:
$ 65.12万 - 项目类别:
Grant-in-Aid for Scientific Research (A)